BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20428379)

  • 1. High hopes for oral cholera vaccine.
    Bull World Health Organ; 2010 Mar; 88(3):165-6. PubMed ID: 20428379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.
    Gupta SS; Bharati K; Sur D; Khera A; Ganguly NK; Nair GB
    Indian J Med Res; 2016 May; 143(5):545-51. PubMed ID: 27487997
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholera vaccine inactivated oral.
    Drugs R D; 1999 Sep; 2(3):193-4. PubMed ID: 10641223
    [No Abstract]   [Full Text] [Related]  

  • 4. An oral cholera vaccine for travelers (Vaxchora).
    Med Lett Drugs Ther; 2016 Aug; 58(1502):113-4. PubMed ID: 27552209
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of vaccination against cholera and typhoid fever.
    Germanier R
    Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated recombinant strains of Vibrio cholerae for oral immunization.
    Srivastava BS; Sinha VB; Srivastava R
    Bull World Health Organ; 1979; 57(4):649-54. PubMed ID: 316742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crisis-driven cholera resurgence switches focus to oral vaccine.
    Bull World Health Organ; 2018 Jul; 96(7):446-447. PubMed ID: 29962546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.
    Clemens JD; Sack DA; Rao MR; Chakraborty J; Khan MR; Kay B; Ahmed F; Banik AK; van Loon FP; Yunus M
    J Infect Dis; 1992 Nov; 166(5):1029-34. PubMed ID: 1402014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of oral cholera vaccines during pregnancy in developing countries.
    Khan AI; Islam MT; Qadri F
    Hum Vaccin Immunother; 2017 Oct; 13(10):2245-2246. PubMed ID: 28825876
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.
    Albert MJ; Alam K; Rahman AS; Huda S; Sack RB
    J Infect Dis; 1994 Mar; 169(3):709-10. PubMed ID: 8158063
    [No Abstract]   [Full Text] [Related]  

  • 15. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera vaccines.
    Kabir S
    Lancet Infect Dis; 2007 Mar; 7(3):176-8; author reply 178. PubMed ID: 17317594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Travellers' compliance with the use of an oral cholera vaccine].
    Cucchi A; Cova M; Merciadri GV; Serenelli C; Ghiselli G; Buriani O; Gabutti G
    Ig Sanita Pubbl; 2010; 66(4):409-18. PubMed ID: 21132038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice.
    Sit B; Zhang T; Fakoya B; Akter A; Biswas R; Ryan ET; Waldor MK
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007417. PubMed ID: 31150386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opportunities & challenges in delivering oral cholera vaccines.
    Deen J; Sack DA
    Indian J Med Res; 2016 Aug; 144(2):149-150. PubMed ID: 27934792
    [No Abstract]   [Full Text] [Related]  

  • 20. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
    Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.